ChemoMetec A/S (CPH:CHEMM)

Denmark flag Denmark · Delayed Price · Currency is DKK
420.40
+7.40 (1.79%)
At close: Feb 27, 2026
-29.93%
Market Cap 7.32B
Revenue (ttm) 493.12M
Net Income (ttm) 177.03M
Shares Out 17.40M
EPS (ttm) 10.17
PE Ratio 41.34
Forward PE 28.22
Dividend 7.00 (1.67%)
Ex-Dividend Date Oct 10, 2025
Volume 56,385
Average Volume 114,694
Open 410.60
Previous Close 413.00
Day's Range 409.00 - 420.40
52-Week Range 367.00 - 804.00
Beta 1.35
RSI 33.17
Earnings Date Feb 4, 2026

About ChemoMetec

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 172
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol CHEMM
Full Company Profile

Financial Performance

In fiscal year 2025, ChemoMetec's revenue was 495.57 million, an increase of 21.50% compared to the previous year's 407.87 million. Earnings were 186.41 million, an increase of 36.78%.

Financial Statements

News

ChemoMetec A/S 2026 Q2 - Results - Earnings Call Presentation

2026-02-11. The following slide deck was published by ChemoMetec A/S in conjunction with their 2026 Q2 earnings call.

18 days ago - Seeking Alpha

Full Year 2025 Chemometec A/S Earnings Call Transcript

Full Year 2025 Chemometec A/S Earnings Call Transcript

4 months ago - GuruFocus

Half Year 2025 Chemometec A/S Earnings Call Transcript

Half Year 2025 Chemometec A/S Earnings Call Transcript

1 year ago - GuruFocus